I regret that it is not possible separately to identify the money devoted to the range of conditions associated with the menopause from the £225 million spent on medical research last year. However, my hon. Friend will be aware of the current work which includes a review of screening techniques for postmenopausal osteoporosis and an economic evaluation of the benefits of hormone replacement therapy.